A detailed history of Group One Trading, L.P. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 2,976 shares of ARWR stock, worth $58,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,976
Previous 586 407.85%
Holding current value
$58,121
Previous $15,000 280.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.36 - $29.54 $46,270 - $70,600
2,390 Added 407.85%
2,976 $57,000
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $12,815 - $16,548
586 New
586 $15,000
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $41,318 - $60,477
1,949 Added 48.59%
5,960 $182,000
Q3 2023

Nov 09, 2023

SELL
$26.2 - $36.08 $253,878 - $349,615
-9,690 Reduced 70.72%
4,011 $107,000
Q2 2023

Aug 09, 2023

BUY
$25.16 - $41.38 $152,041 - $250,059
6,043 Added 78.91%
13,701 $488,000
Q1 2023

May 12, 2023

SELL
$23.68 - $38.51 $712,768 - $1.16 Million
-30,100 Reduced 79.72%
7,658 $194,000
Q4 2022

Feb 09, 2023

BUY
$28.0 - $40.56 $432,572 - $626,611
15,449 Added 69.25%
37,758 $1.53 Million
Q3 2022

Nov 09, 2022

BUY
$29.63 - $48.31 $143,231 - $233,530
4,834 Added 27.66%
22,309 $737,000
Q2 2022

Aug 11, 2022

SELL
$27.79 - $50.61 $51,744 - $94,235
-1,862 Reduced 9.63%
17,475 $615,000
Q1 2022

May 12, 2022

SELL
$39.62 - $69.97 $2.28 Million - $4.02 Million
-57,443 Reduced 74.82%
19,337 $889,000
Q4 2021

Feb 11, 2022

BUY
$58.09 - $82.51 $23,236 - $33,004
400 Added 0.52%
76,780 $5.09 Million
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $662,904 - $964,720
11,355 Added 17.46%
76,380 $4.77 Million
Q2 2021

Aug 10, 2021

SELL
$62.15 - $90.32 $145,493 - $211,439
-2,341 Reduced 3.48%
65,025 $5.39 Million
Q1 2021

May 12, 2021

BUY
$61.35 - $90.47 $1.87 Million - $2.75 Million
30,416 Added 82.32%
67,366 $4.47 Million
Q4 2020

Feb 10, 2021

SELL
$43.82 - $85.37 $1.63 Million - $3.17 Million
-37,154 Reduced 50.14%
36,950 $2.84 Million
Q3 2020

Nov 12, 2020

BUY
$33.21 - $51.27 $1.66 Million - $2.57 Million
50,033 Added 207.86%
74,104 $3.19 Million
Q2 2020

Aug 13, 2020

SELL
$26.12 - $43.27 $1.63 Million - $2.69 Million
-62,278 Reduced 72.12%
24,071 $1.04 Million
Q1 2020

May 13, 2020

BUY
$20.56 - $63.12 $1.29 Million - $3.95 Million
62,627 Added 264.0%
86,349 $2.48 Million
Q4 2019

Feb 10, 2020

BUY
$28.14 - $73.01 $132,454 - $343,658
4,707 Added 24.75%
23,722 $1.51 Million
Q3 2019

Nov 12, 2019

BUY
$26.26 - $34.86 $499,333 - $662,862
19,015 New
19,015 $536,000
Q2 2019

Aug 09, 2019

SELL
$17.43 - $28.82 $435,872 - $720,701
-25,007 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$12.05 - $20.18 $155,553 - $260,503
-12,909 Reduced 34.05%
25,007 $459,000
Q4 2018

Feb 06, 2019

BUY
$10.74 - $19.7 $407,217 - $746,945
37,916 New
37,916 $471,000
Q3 2018

Nov 08, 2018

SELL
$14.0 - $20.3 $109,102 - $158,197
-7,793 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$6.37 - $14.02 $388,219 - $854,448
-60,945 Reduced 88.66%
7,793 $106,000
Q1 2018

May 11, 2018

BUY
$3.72 - $7.64 $255,705 - $525,158
68,738 New
68,738 $496,000
Q3 2017

Nov 15, 2017

SELL
$1.69 - $4.33 $178,443 - $457,196
-105,588 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
105,588
105,588 $171,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.